PNPLA5 anticorps (N-Term)
Aperçu rapide pour PNPLA5 anticorps (N-Term) (ABIN629699)
Antigène
Voir toutes PNPLA5 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Specificité
- PNPLA5 antibody was raised against the N terminal of PNPLA5
-
Purification
- Purified
-
Immunogène
- PNPLA5 antibody was raised using the N terminal of PNPLA5 corresponding to a region with amino acids LSLSILHPAYAPIEHVKQQLQDALPPDAHVLASQRLGISLTRWPDGRNFL
-
-
-
-
Indications d'application
-
WB: 2.5 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
PNPLA5 Blocking Peptide, (ABIN5615441), is also available for use as a blocking control in assays to test for specificity of this PNPLA5 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of PNPLA5 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- PNPLA5 (Patatin-Like phospholipase Domain Containing 5 (PNPLA5))
-
Autre désignation
- PNPLA5
-
Sujet
- Human patatin-like phospholipases, such as PNPLA5, have been implicated in regulation of adipocyte differentiation and have been induced by metabolic stimuli.Human patatin-like phospholipases, such as PNPLA5, have been implicated in regulation of adipocyte differentiation and have been induced by metabolic stimuli.
-
Poids moléculaire
- 48 kDa (MW of target protein)
Antigène
-